SAB Biotherapeutics reports FY results
Source: SeekingAlpha
2026-03-09 17:22:20 ET
More on SAB Biotherapeutics
- Seeking Alpha’s Quant Rating on SAB Biotherapeutics
- Historical earnings data for SAB Biotherapeutics
- Financial information for SAB Biotherapeutics
Read the full article on Seeking Alpha
For further details see:
SAB Biotherapeutics reports FY results
SAB Biotherapeutics Inc.
NASDAQ: SABS
SABS Trading
7.32% G/L:
$4.105 Last:
336,731 Volume:
$4.05 Open:
SABS Latest News
March 10, 2026 07:31:00 am
SAB BIO Announces Additional Phase 1 Data for SAB-142 in Adult Patients with Established Autoimmune Type 1 Diabetes
January 07, 2026 08:00:00 am
SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director
SABS Stock Data
$198,996,637
35,676,574
26.21%
14
N/A
Biotechnology & Life Sciences
Healthcare
US
Miami Beach
